Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial Cells

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 143; no. 8; pp. 865 - 868
Main Authors McCracken, Ian R., Saginc, Gaye, He, Liqun, Huseynov, Alik, Daniels, Alison, Fletcher, Sarah, Peghaire, Claire, Kalna, Viktoria, Andaloussi-Mäe, Maarja, Muhl, Lars, Craig, Nicky M., Griffiths, Samantha J., Haas, Jürgen G., Tait-Burkard, Christine, Lendahl, Urban, Birdsey, Graeme M., Betsholtz, Christer, Noseda, Michela, Baker, Andrew H., Randi, Anna M.
Format Journal Article
LanguageEnglish
Published United States Lippincott Williams & Wilkins 23.02.2021
Subjects
angiotensin-converting enzyme 2
Angiotensin-Converting Enzyme 2 - genetics
Angiotensin-Converting Enzyme 2 - physiology
Correspondence
COVID-19
endothelial cells
Endothelial Cells - enzymology
Endothelial Cells - virology
endothelial injury
Humans
SARS-CoV-2
SARS-CoV-2 - physiology
Virus Replication
COVID-19
SARS-CoV-2
endothelial cells
angiotensin-converting enzyme 2
endothelial injury
Online AccessGet full text

Cover

More Information
Bibliography:content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ISSN:0009-7322
1524-4539
1524-4539
DOI:10.1161/CIRCULATIONAHA.120.052824